source
- FDA faces push for flexible rare-disease trial designs as commissioner's nomination withdrawnThe FDA’s weekly briefing highlighted several notable developments, including the sudden withdrawal of the Trump administration’s nominee for FDA commissioner at the last minute. The agency also a…
- Ailux appoints former Johnson & Johnson executive Lloyd Miller as chief medical officerAilux announced the hiring of Lloyd Miller as its new chief medical officer. Miller comes from Johnson & Johnson where he served as senior vice president and global head of translational science &…